Saneron CCEL Therapeutics, Inc.

Saneron is a biotechnology R&D company, focused on neurological and cardiac cell therapy for the early intervention and treatment of several devastating or deadly diseases, which lack adequate treatment options. Saneron, a University of South Florida spin-out company is located at the Tampa Bay Technology Incubator. An affiliate of Cryo-Cell International, Inc. Saneron is committed to providing readily available, non-controversial, ethically acceptable cells, both stem cells and other cell types, for cellular therapies. Saneron has patented and patent-pending technology relating to our platform technology of: U-CORD-CELL - Umbilical cord blood and SERT-CELLTM - Sertoli cells.